Skip to Content

12 Results Found

  • Article
  • Open Access
15 Citations
5,216 Views
24 Pages

Synergistic Activation of VDR-RXR Heterodimers by Vitamin D and Rexinoids in Human Kidney and Brain Cells

  • Mobin Emran Doost,
  • Jennifer Hong,
  • Jennifer E. Broatch,
  • Michael T. Applegate and ,
  • Carl E. Wagner,
  • Pamela A. Marshall and
  • Peter W. Jurutka
  • + 2 authors+ 0 author

14 November 2024

The active form of vitamin D, 1,25-dihydroxyvitamin D (1,25D), binds to the vitamin D receptor (VDR) with high affinity. The VDR then heterodimerizes with the retinoid X receptor (RXR) and associates with vitamin D response elements (VDREs) to regula...

  • Review
  • Open Access
5 Citations
1,925 Views
45 Pages

Targeting Multidrug Resistance in Cancer: Impact of Retinoids, Rexinoids, and Carotenoids on ABC Transporters

  • Martina Čižmáriková,
  • Viktória Háziková,
  • Radka Michalková,
  • Ondrej Franko and ,
  • Beáta Lešková,
  • Atila David Homolya,
  • Juliana Gabzdilová and
  • Peter Takáč
  • + 3 authors+ 0 author

18 November 2025

The active efflux of drugs by adenosine triphosphate (ATP)-binding cassette (ABC) trans-porters, such as multidrug resistance protein 1 (MDR1/ABCB1), multidrug resistance-associated protein 1 and 2 (MRP1/ABCC1; MRP2/ABCC2), and breast cancer resistan...

(This article belongs to the Special Issue Anti-Cancer, Anti-Inflammatory, and Antioxidation Active Substances: 3rd Edition)
  • Article
  • Open Access
1,365 Views
22 Pages

1,25-Dihydroxyvitamin D Induces a NURR1–Tyrosine Hydroxylase Transcriptional Axis Modulated by Rexinoid/RXR Signaling in Parkinson’s Disease-Relevant Human Neural Cell Models

  • Michael A. Sausedo,
  • Sanchita Mallick,
  • Zhela L. Sabir,
  • Sarah Livingston and ,
  • Quang T. Nguyen,
  • Mobin Emran Doost,
  • Carl E. Wagner,
  • Pamela A. Marshall,
  • Carol A. Haussler and
  • Peter W. Jurutka
  • + 6 authors+ 1 author

3 July 2026

The hormonal vitamin D metabolite, 1,25-dihydroxyvitamin D (1,25D), produced primarily in the kidney, acts in numerous end-organs via the nuclear vitamin D receptor (VDR) to trigger molecular events that orchestrate bone mineral homeostasis, immune r...

(This article belongs to the Special Issue Molecular and Cellular Drivers of Parkinson's Disease)
  • Article
  • Open Access
8 Citations
4,728 Views
22 Pages

An Isochroman Analog of CD3254 and Allyl-, Isochroman-Analogs of NEt-TMN Prove to Be More Potent Retinoid-X-Receptor (RXR) Selective Agonists Than Bexarotene

  • Peter W. Jurutka,
  • Orsola di Martino,
  • Sabeeha Reshi,
  • Sanchita Mallick and ,
  • Michael A. Sausedo,
  • Grant A. Moen,
  • Isaac J. Lee,
  • Dominic J. Ivan,
  • Tyler D. Krall and
  • Carl E. Wagner
  • + 20 authors+ 15 authors

19 December 2022

Bexarotene is an FDA-approved drug for the treatment of cutaneous T-cell lymphoma (CTCL); however, its use provokes or disrupts other retinoid-X-receptor (RXR)-dependent nuclear receptor pathways and thereby incites side effects including hypothyroid...

(This article belongs to the Special Issue Novel Strategies in the Development of New Therapies, Drug Substances and Drug Carriers 2.0)
  • Article
  • Open Access
9 Citations
5,006 Views
19 Pages

Development of Bexarotene Analogs for Treating Cutaneous T-Cell Lymphomas

  • Ankedo Warda,
  • Lech J. P. Staniszewski,
  • Zhela Sabir,
  • Sarah Livingston and ,
  • Michael Sausedo,
  • Sabeeha Reshi,
  • Eyal Ron,
  • Michael T. Applegate,
  • Dena Haddad and
  • Peter W. Jurutka
  • + 8 authors+ 3 authors

4 November 2023

Bexarotene, a drug approved for treatment of cutaneous T-cell lymphoma (CTCL), is classified as a rexinoid by its ability to act as a retinoid X receptor (RXR) agonist with high specificity. Rexinoids are capable of inducing RXR homodimerization lead...

  • Article
  • Open Access
10 Citations
6,646 Views
41 Pages

Modeling, Synthesis, and Biological Evaluation of Potential Retinoid-X-Receptor (RXR) Selective Agonists: Analogs of 4-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahyro-2-naphthyl)ethynyl]benzoic Acid (Bexarotene) and 6-(Ethyl(4-isobutoxy-3-isopropylphenyl)amino)nicotinic Acid (NEt-4IB)

  • Peter W. Jurutka,
  • Orsola di Martino,
  • Sabeeha Reshi,
  • Sanchita Mallick and ,
  • Zhela L. Sabir,
  • Lech J. P. Staniszewski,
  • Ankedo Warda,
  • Emma L. Maiorella,
  • Ani Minasian and
  • Carl E. Wagner
  • + 19 authors+ 14 authors

16 November 2021

Five novel analogs of 6-(ethyl)(4-isobutoxy-3-isopropylphenyl)amino)nicotinic acid—or NEt-4IB—in addition to seven novel analogs of 4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic acid (bexarotene) were prepared and evaluate...

(This article belongs to the Special Issue Medicinal Chemistry of Nuclear Receptors)
  • Brief Report
  • Open Access
1,428 Views
14 Pages

24 September 2025

We have previously established that bexarotene, a clinically approved agonist of retinoid X receptor (RXR), promotes the differentiation and fusion of skeletal myoblasts. We have also analyzed the genomic programs underlying rexinoid-enhanced myogeni...

  • Review
  • Open Access
201 Citations
35,669 Views
14 Pages

Retinoic Acid and Its Derivatives in Skin

  • Łukasz Szymański,
  • Rafał Skopek,
  • Małgorzata Palusińska,
  • Tino Schenk and ,
  • Sven Stengel,
  • Sławomir Lewicki,
  • Leszek Kraj,
  • Paweł Kamiński and
  • Arthur Zelent
  • + 4 authors+ 0 author

11 December 2020

The retinoids are a group of compounds including vitamin A and its active metabolite all-trans-retinoic acid (ATRA). Retinoids regulate a variety of physiological functions in multiple organ systems, are essential for normal immune competence, and ar...

(This article belongs to the Section Cell Nuclei: Function, Transport and Receptors)
  • Article
  • Open Access
2 Citations
3,951 Views
25 Pages

RAR-Dependent and RAR-Independent RXR Signaling in Stem-like Glioma Cells

  • Amanda Dabrock,
  • Natalie Ernesti,
  • Florian Will,
  • Manaf Rana and ,
  • Nadja Leinung,
  • Phillip Ehrich,
  • Volker Tronnier and
  • Christina Zechel
  • + 3 authors+ 0 author

17 November 2023

Retinoic acid (RA) exerts pleiotropic effects during neural development and regulates homeostasis in the adult human brain. The RA signal may be transduced through RXR (retinoid-X receptor)-non-permissive RA receptor/RXR heterodimers or through RXR-p...

(This article belongs to the Section Molecular Oncology)
  • Article
  • Open Access
11 Citations
4,299 Views
17 Pages

22 August 2018

We conducted an in vitro study combining a rexinoid, 6-OH-11-O-hydroxyphenanthrene (IIF), and epigallocatechin-3-gallate (EGCG), which is the main catechin of green tea, on BE(2)-C, a neuroblastoma cell line representative of the high-risk group of p...

(This article belongs to the Special Issue Tea in Health and Disease)
  • Article
  • Open Access
5 Citations
1,538 Views
16 Pages

A Novel Rexinoid Agonist, UAB116, Decreases Metastatic Phenotype in Hepatoblastoma by Inhibiting the Wnt/β-Catenin Pathway via Upregulation of TRIM29

  • Swatika Butey,
  • Morgan L. Brown,
  • Janet R. Julson,
  • Raoud Marayati and ,
  • Venkatram R. Atigadda,
  • Maryam G. Shaikh,
  • Nazia Nazam,
  • Colin H. Quinn,
  • Sorina Shirley and
  • Elizabeth A. Beierle
  • + 6 authors+ 1 author

Hepatoblastoma (HB) is the most common pediatric primary liver tumor. About 20% of affected children have pulmonary metastasis at presentation. Survival rates for these children are dismal, not exceeding 25%. To study this subset of patients, we sequ...

(This article belongs to the Section Biochemistry)
  • Article
  • Open Access
5 Citations
3,420 Views
15 Pages

24 August 2022

Therapeutic targets in cancer cells defective for the tumor suppressor ARID1A are fundamentals of synthetic lethal strategies. However, whether modulating ARID1A function in premalignant breast epithelial cells could be exploited to reduce carcinogen...

(This article belongs to the Section Cell Signaling)